Improved anti-cancer effect of epidermal growth factor-gold nanoparticle conjugates by protein orientation through site-specific mutagenesis
Epidermal growth factor (EGF)-nanoparticle conjugates have the potential for cancer therapeutics due to the unique cytotoxic activity in cancer cells with EGF receptor (EGFR) overexpression. To gain its maximum activity, the EGF molecule should be immobilized on the nanoparticle surface in a defined...
Main Authors: | Aiwen Zhang, Jun Nakanishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-12-01
|
Series: | Science and Technology of Advanced Materials |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14686996.2021.1944783 |
Similar Items
-
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
by: Alberto Juan, et al.
Published: (2020-08-01) -
Enhancement of Skin Wound Healing by rhEGF-Loaded Carboxymethyl Chitosan Nanoparticles
by: Pei Zhang, et al.
Published: (2020-07-01) -
EGF Conjugation Improves Safety and Uptake Efficacy of Titanium Dioxide Nanoparticles
by: Basma Salama, et al.
Published: (2020-09-01) -
Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains
by: Tímea Hajdu, et al.
Published: (2020-08-01) -
Targeting Cancer Resistance via Multifunctional Gold Nanoparticles
by: Pedro Pedrosa, et al.
Published: (2019-11-01)